Florian Piekarski: How Structured PBM Provides an Evidence-Based Framework for Jehovah’s Witnesses
Florian Piekarski, Senior Physician in Charge in the Department of Anesthesiology at University Hospital Bonn, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Anesthesiology, adding:
”Just published: Perioperative Blood Management in Jehovah’s Witnesses
Jehovah’s Witnesses decline allogeneic blood products on religious grounds, a reality that demands individualized, ethically grounded, and medically sound perioperative strategies.
Our paper addresses exactly this challenge.
What we cover:
- How structured Patient Blood Management (PBM) provides an evidence-based framework for this patient group
- Preoperative anemia treatment and intraoperative coagulation management
- The role of viscoelastic point-of-care diagnostics and mechanical autotransfusion
- The legal landscape around advance directives, including special considerations for children
- A differentiated informed consent questionnaire developed at the University of Bonn
Key takeaway:
A well-designed, individualized PBM concept can ensure perioperative safety while fully respecting patient autonomy.
Medical excellence and ethical sensitivity are not in conflict.
They go hand in hand.”
Title: Perioperative Blood Management in Jehovah’s Witnesses
Authors: Florian Piekarski, Jan Menzenbach, Tobias Hilbert, Jürgen Hersch, Ehrenfried Schindler, Mark Coburn, Josefin Grabert

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines